Why the study?
Since the 2021 APSC consensus statements on MitraClip for MR, newer TEER devices have been introduced for treating both TR and MR, necessitating updated regional recommendations on appropriate TEER use.
What is the appropriate patient selection, evaluation, and clinical management for transcatheter edge-to-edge repair (T-TEER and M-TEER) in patients with tricuspid or mitral regurgitation in the Asia-Pacific region?
What is the appropriate patient selection, evaluation, and clinical management for transcatheter edge-to-edge repair (T-TEER and M-TEER) in patients with tricuspid or mitral regurgitation in the Asia-Pacific region?
Provides updated, regionally contextualized consensus guidance (16 statements) from the Asian Pacific Society of Cardiology on patient selection, imaging, Heart Team evaluation, and use of both tricuspid and mitral TEER devices.
Answers are grounded in this paper and cite their sources.
Offers region-specific TEER guidance for TR/MR in Asia-Pacific; extends global consensus with tailored recommendations for clinicians and researchers.
Since the publication of the 2021 Asian Pacific Society of Cardiology (APSC) consensus statements on the use of MitraClip for mitral regurgitation (MR), other transcatheter edge-to-edge repair (TEER) devices have been introduced for the treatment of both tricuspid regurgitation (TR) and MR. Hence, the APSC developed these consensus recommendations, with general cardiologists and internal medicine specialists practicing cardiology as the intended readers, to update the recommendations on the appropriate use of TEER in patients with TR or MR. The APSC expert panel reviewed and appraised the available evidence using the GRADE system. Consensus recommendations were developed and put to an online vote. Consensus was reached when at least 80% of votes for a given recommendation were in support of 'agree' or 'neutral', The resulting 16 statements provide guidance for clinical practitioners in the region on the evaluation and management of patients with TR or MR in the Asia-Pacific region who are being considered for TEER therapy.
No takes yet. Share an insight, caveat, or question.
Yeo et al. (2026) studied Tricuspid regurgitation and mitral regurgitation. Transcatheter edge-to-edge repair (TEER, including T-TEER and M-TEER) vs. Medical therapy alone or surgical valve repair/replacement was evaluated on Consensus agreement (defined as ≥80% 'agree' or 'neutral' votes by the expert panel) on clinical practice statements. The Asian Pacific Society of Cardiology expert panel developed 16 consensus statements guiding transcatheter edge-to-edge repair for tricuspid and mitral regurgitation.
Synapse has enriched 10 related papers. Consider them for comparative context: